A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.

@article{Hossen2013ACS,
  title={A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.},
  author={Nazir Hossen and K. Kajimoto and H. Akita and M. Hyodo and H. Harashima},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  year={2013},
  volume={171 2},
  pages={
          104-12
        }
}
Antiangiogenesis has been the focus of a new strategy for the treatment of obesity. However, little is known regarding the issue of whether targeting angiogenesis by nanoparticle-targeted therapeutic is advantageous or not in debugging the co-morbidity associated with diet-induced obesity (DIO) and the metabolic syndrome. We report herein on the positive effect of prohibitin (an adipose vascular marker)-targeted nanoparticle (PTNP) encapsulated in a proapoptotic peptide [(D)(KLAKLAK)₂, KLA] on… Expand
Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.
TLDR
For targeting tumor vasculatur, a new strategy referred to as dual-targeting is proposed that uses a combination of a receptor specific ligand and a cell penetrating peptide, which can induce the synergistic enhancement of tissue selectivity under in vivo conditions. Expand
Vascular targeted nanotherapeutic approach for obesity treatment
TLDR
Independent studies have shown improved drug efficacy by using prohibitin (PHB)-targeted therapy in obese rodents and non-human primates, thus providing a proof of concept that targeted nanotherapy can be a feasible treatment for obesity. Expand
Advances in an active and passive targeting to tumor and adipose tissues
TLDR
The focus of this review is on active targeting as a next-generation strategy for extending the capacity of a drug delivery system (DDS) to adipose tissue via the enhanced permeability and retention-effect. Expand
A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue.
TLDR
It is concluded that the increased energy expenditure via adipose tissue browning using dual-targeted Rs-NP is a promising strategy for the treatment of obesity and its related metabolic syndrome. Expand
Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier
TLDR
Comparisons of PTNP prepared by the reverse-phase evaporation (REV) and lipid film hydration (HYD) methods with reference to physicochemical characteristics and in vivo and in vitro behavior revealed that the irreversible alteration in ligand conformation was caused by the organic solvent used to prepare the thin lipid film. Expand
Nanotechnology-Mediated Drug Delivery for the Treatment of Obesity and Its Related Comorbidities.
TLDR
This review provides an introduction to obesity and obesity-related comorbidities, and the most recent developments of nanotechnology-based drug delivery strategies are highlighted and discussed. Expand
APPLICATION OF NANOTECHNOLOGY IN FOOD TECHNOLOGY AND TARGETED DRUG THERAPY FOR PREVENTION OF OBESITY: AN OVERVIEW
TLDR
Nanoparticle Targeted drug therapy, particularly for adipose tissue, may provide a new generation formulation for therapeutics of obesity. Expand
Identification and characterization of adipose surface epitopes
TLDR
It is discussed that, while no unique adipocyte surface protein might exist, how splicing, posttranslational modifications as well as protein/protein interactions can create enormous diversity at the cell surface that vastly expands the space of potentially unique epitopes and how these selective epitopes can be identified and targeted. Expand
Nanomaterials for the theranostics of obesity.
TLDR
Therapies of obesity with nanomaterials include improving intestinal health and reducing energy intake, targeting and treating functional cell abnormalities, regulating redox homeostasis, and removing free lipoprotein in blood. Expand
Herbal nanotherapy: A new paradigm over conventional obesity treatment
TLDR
The present review focusses on the various nanocarrier approaches for the delivery of herbal drugs as an alternative anti-obesity treatment that proved to be a therapy with lesser side effects and improved therapeutic efficacy. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 30 REFERENCES
Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.
TLDR
The systemic administration of a proapoptotic peptide with the delivery via PTNP significantly reduced the body weight of DIO mice, as evidenced by the targeted ablation of adipose endothelial cells. Expand
Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system.
TLDR
Intravenous treatment of CytC-loaded PTNP resulted in a substantial reduction in obesity in high-fat diet fed wild-type (wt) mice, as evidenced by the dose-dependent prevention of the percentage of increase in body weight and decrease in serum leptin levels. Expand
Reversal of obesity by targeted ablation of adipose tissue
TLDR
An antiobesity therapy based on targeted induction of apoptosis in the vasculature of adipose tissue resulted in rapid obesity reversal without detectable adverse effects and may lead to the development of targeted drugs for treatment of obese patients. Expand
Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
Ligand-based targeted delivery is an emerging platform in nanomedicine. We report herein on a peptide modified nanocarrier for a ligand-based targeted delivery system. The liposomal surface of theExpand
Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice
TLDR
It is shown that systemic administration of a selective angiogenesis inhibitor, TNP-470 (AGM-1470), prevents obesity in high caloric diet-fed wt mice as well as in genetically leptin-deficient ob/ob mice, suggesting that similarly to growth and organogenesis in other tissues, adipose tissue growth is dependent onAngiogenesis. Expand
A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys
TLDR
Evaluated ligand-directed peptidomimetic CKGGRAKDC-GG-D(KLAKLAK)2 (henceforth termed adipotide) in obese Old World monkeys resulted in a reduction in body mass, an improvement in insulin resistance, and a decrease in abdominal circumference, key predictors of diabetes in humans. Expand
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
  • Yihai Cao
  • Biology, Medicine
  • Nature Reviews Drug Discovery
  • 2010
TLDR
Recent progress is discussed in understanding the molecular mechanisms that control adipose tissue angiogenesis and in defining potential new vascular targets and approaches for the treatment of this group of diseases. Expand
Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice
TLDR
In this model, growth and development of adipose tissue appears to be limited by the formation of a collagen-rich matrix cap around the inhibitor-treated tissue, suggesting a functional role for MMPs in the development of fat tissue. Expand
Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice.
TLDR
The curcumin suppression of angiogenesis in adipose tissue together with its effect on lipid metabolism in adipocytes may contribute to lower body fat and body weight gain. Expand
Obesity is associated with macrophage accumulation in adipose tissue.
TLDR
Transcript expression in perigonadal adipose tissue from groups of mice in which adiposity varied due to sex, diet, and the obesity-related mutations agouti (Ay) and obese (Lepob) found that the expression of 1,304 transcripts correlated significantly with body mass. Expand
...
1
2
3
...